Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
Israel
access_time 16 April 2024 5:09 AM GMT
Peoples priority is livelihood issues
access_time 12 April 2024 4:30 AM GMT
The survival challenge before the CPM
access_time 10 April 2024 5:05 AM GMT
NATO
access_time 9 April 2024 4:00 AM GMT
DEEP READ
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Ramadan: Its essence and lessons
access_time 13 March 2024 9:24 AM GMT
exit_to_app
Homechevron_rightSciencechevron_rightCancer vaccines to be...

Cancer vaccines to be available by 2030, says BioNTech

text_fields
bookmark_border
Cancer vaccines to be available by 2030, says BioNTech
cancel

Vaccines that treat cancer could be available by 2030, said co-founders of BioNTechUğur Şahin and Özlem Türeci. The German firm is known to partner with Pfizer to manufacture the mRNA Covid vaccine that saved countless lives during the pandemic.

The researchers are planning to develop treatments for bowel cancer and melanoma among other types.

Speaking to BBC, Türeci said the same mRNA technology can be repurposed to prepare the immune system to attack cancer cells. The Covid vaccine works by taking genetic instructions for harmless spike protein on Covid virus into the body. The cells create the same spoke protein which attracts the attention of the immune system. The antibodies and other defences of the body will search for and attack the pathogen. The same approach can be used to seek and destroy cancer cells.

Türeci, BioNTech's chief medical officer, said the cancer vaccine will contain genetic instructions for cancer antigens instead of code to identify viruses. Cancer antigens are proteins that stud the surfaces of tumour cells. The main challenge is to tailor the vaccine to target cancer cells and stay away from healthy tissues. The firm already has several cancer vaccines in clinical trials.

Show Full Article
TAGS:covid vaccinecancerBioNTechcancer cure
Next Story